Huidschimmelcrème Terbinafine Hcl Etos (Terbinafine Hydrochloride)

Huidschimmelcrème Terbinafine Hcl Etos is indicated for the topical treatment of common dermatophyte infections that affect the skin, hair, or nails, and it may be used under medical supervision for confirmed fungal conditions.

• Tinea corporis (ringworm of the body)
• Tinea pedis (athlete’s foot)
• Tinea cruris (jock itch)
• Tinea unguium (fungal nail infection of the toe or finger)
• Other superficial dermatophyte infections confirmed by a healthcare professional
• Superficial cutaneous candidiasis (when caused by susceptible species)

• Terbinafine hydrochloride belongs to the allylamine class of antifungals and acts by inhibiting the fungal enzyme squalene epoxidase. This blockade prevents the conversion of squalene to lanosterol, a key step in ergosterol synthesis. The resulting accumulation of squalene is toxic to fungal cells, while the depletion of ergosterol disrupts membrane integrity, leading to fungal cell death. Because the target enzyme is absent in human cells, systemic absorption from topical use is minimal, contributing to a favorable safety profile.

Topical terbinafine may cause local skin reactions, although many users experience no adverse effects; most events are mild and resolve after discontinuation.

Common

• Mild burning or stinging at the application site
• Itching or mild rash
• Redness or mild irritation
• Swelling of the treated area
• Sensation of tingling or numbness

Serious

• Severe allergic reaction (e.g., angioedema, anaphylaxis) requiring immediate medical attention
• Contact dermatitis with extensive blistering and oozing that may spread beyond the application site
• Persistent swelling, hives, or urticaria that does not subside after stopping the cream

When using Huidschimmelcrème Terbinafine Hcl Etos, certain precautions should be observed to minimize risk and ensure appropriate therapy.

• Do not apply to broken, inflamed, or infected skin not caused by dermatophytes.
• Avoid contact with eyes, mucous membranes, or open wounds.
• Use only on the skin area for which the product is intended; do not cover with occlusive dressings unless directed by a healthcare professional.
• Discontinue use and seek medical advice if a rash, severe irritation, or signs of an allergic reaction develop.
• Keep the cream out of reach of children and store at room temperature away from direct sunlight.

Topical terbinafine has a low potential for systemic drug interactions, but certain substances may affect its safety or efficacy when used concurrently.

Avoid

• Avoid using other topical antifungal agents on the same area without medical guidance, as combined use may increase irritation.
• Avoid applying the cream on skin treated with strong keratolytic agents (e.g., salicylic acid) that could enhance systemic absorption.

Use with caution

• Use with caution in patients using systemic terbinafine or other allylamine antifungals, to prevent additive exposure.
• Use with caution when applying near large skin surfaces or under occlusion, as this may increase local absorption.
• Use with caution in individuals with known hypersensitivity to terbinafine or related compounds.